Vernon K. Sondak, MD, chair of the Department of Cutaneous Oncology at Moffitt Cancer Center, discusses the use of ipilimumab in the adjuvant setting for patients with melanoma.
Vernon K. Sondak, MD
Advertisement
Articles by Vernon K. Sondak, MD
Vernon K. Sondak, MD, talks about personalized medicine when treating patients with melanoma.
Advertisement
Latest Updated Articles
Personalized Medicine in MelanomaPublished: October 9th 2013 | Updated:
Ipilimumab in the Adjuvant Setting for MelanomaPublished: October 18th 2013 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
